Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04230759
Title Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group (RADIANCE)
Acronym RADIANCE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Goethe University
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU | AUT


No variant requirements are available.